Financial Performance - Net profit attributable to shareholders was CNY -3,383,633.75, a decline of 391.39% year-on-year[7] - Operating revenue fell by 39.98% to CNY 24,986,300.53 compared to the same period last year[7] - Basic earnings per share were CNY -0.0278, down 392.63% from CNY 0.0095 in the same period last year[7] - The company reported a total comprehensive loss of CNY 3,485,478.85 for Q1 2015, compared to a comprehensive income of CNY 459,033.57 in Q1 2014[28] - Net profit for Q1 2015 was a loss of CNY 3,485,478.85, compared to a profit of CNY 459,033.57 in Q1 2014, marking a significant decline[28] Revenue and Costs - Operating costs decreased by 34.87% to CNY 18,411,139.04 from CNY 28,267,892.89, reflecting the decline in sales revenue[13] - Total operating revenue for Q1 2015 was CNY 24,986,300.53, a decrease of 40% compared to CNY 41,633,208.91 in the same period last year[26] - Total operating costs for Q1 2015 were CNY 28,299,509.56, down 37% from CNY 44,841,012.77 year-over-year[27] - The company experienced a 72.73% reduction in selling expenses, which fell to CNY 2,510,358.21 from CNY 9,205,308.11, correlating with the decline in sales revenue[13] - Cash paid for purchasing goods and services in Q1 2015 was CNY 16,882,839.46, an increase from CNY 8,602,206.40 in the same period last year[30] Cash Flow - Net cash flow from operating activities was CNY -5,625,090.30, a decrease of 713.56% compared to the previous year[7] - The net cash flow from operating activities was -353,842.42 RMB, compared to -1,962,573.51 RMB in the previous year, indicating an improvement[34] - Total cash inflow from operating activities was 12,163,007.09 RMB, while cash outflow was 12,516,849.51 RMB, resulting in a net cash outflow of 353,842.42 RMB[34] - Cash flow from investment activities resulted in a net outflow of -101,800.00 RMB, compared to a net inflow of 1,043,170.00 RMB in the previous year[34] - The cash flow from operating activities showed a slight improvement year-over-year, indicating potential operational efficiency gains[34] Assets and Liabilities - Total assets decreased by 3.88% to CNY 277,140,971.88 compared to the end of the previous year[7] - Current assets decreased from ¥127,296,942.18 to ¥116,008,157.12, a reduction of about 8.5%[20] - Total liabilities decreased from ¥200,176,843.70 to ¥192,464,798.39, a decline of about 3.4%[21] - Owner's equity decreased from ¥88,161,652.34 to ¥84,676,173.49, a reduction of approximately 4.4%[21] - Cash and cash equivalents decreased from ¥29,072,092.28 to ¥23,113,413.44, a decline of about 20.4%[20] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,100[10] - The largest shareholder held 11.73% of the shares, amounting to 14,285,055 shares[10] Regulatory and Corporate Governance - The company has received a notice from the China Securities Regulatory Commission regarding an ongoing investigation for suspected violations of securities laws[14] - The company and its major shareholders have committed not to discuss major asset restructuring matters for six months starting from July 29, 2014[15] - The company anticipates significant changes in net profit compared to the previous year, but specific forecasts are not applicable at this time[15] Other Financial Metrics - The weighted average return on net assets decreased by 5.65 percentage points to -4.2317%[7] - Government subsidies recognized in the current period amounted to CNY 2,540,234.23[8] - Non-operating income and expenses totaled CNY 42,927.59, after accounting for various non-recurring items[8] - The company reported a decrease in prepayments by 59.79%, from CNY 2,879,171.58 to CNY 1,157,797.67, due to the receipt of invoices for previously paid amounts[13] - Other receivables decreased by 66.26% to CNY 980,423.29, primarily due to the recovery of various payments[13]
*ST目药(600671) - 2015 Q1 - 季度财报